New PCSK9 Inhibitor Allows 3-Month Treatment Intervals
"It's a new antibody that has a long half-life so each treatment can be prolonged."
Source: medscape.com
Page 9 - Ipid Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ipid Management Today - Breaking & Trending Today
Late-Life Increases in Pulmonary Pressure, Hypertension
Age-related increases in pulmonary artery systolic pressure occur in concert with worsening left ventricular diastolic dysfunction and contribute to late-life dyspnea, new data show.
Source: medscape.com
Promising First Results With DNA Editing to Lower LDL
The first-in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial hypercholesterolemia.
Source: medscape.com
Novel Agent Seladelpar Improves Markers of PBC Activity
For 1 in 4 patients with primary biliary cholangitis (PBC) who received the investigational PPAR-delta agonist, alkaline phosphatase levels normalized.
Source: medscape.com
Study Takes Fine-Grained Look at MACE Risk With GCs in RA
'Up to half of RA patients in the United States use long-term glucocorticoids despite previous work suggesting they increase MACE in a dose-dependent way.'
Source: medscape.com